UnknownNot Applicable

Cohorte Nationale VIH-2

France1,185 participantsStarted 1994-01-01

Plain-language summary

The HIV2 study is an open cohort of prospective, multicentric, national observation. The main objective is to study HIV-2 infection in adult patients followed in France.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * HIV-2 infection only, diagnosed by ELISA, confirmed by Western-Blot test, * Follow-up in consultation or hospitalization in one of the investigating centers, * Age greater than or equal to 18 years, * Prolonged follow-up possible, residence in France planned for at least one year, * Consent to participate, * Long-term medical care possible for the participant, or by medical aid (AME), or declaration of obtaining AME at the time of inclusion. Exclusion Criteria: * HIV-1 infection * Double HIV-1 + HIV-2 seropositivity

What they're measuring

Study HIV-2 infection rate in adult patients followed in France

Timeframe: At the baseline

Trial details

NCT IDNCT04658329

SponsorANRS, Emerging Infectious Diseases

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2022-09-30

Contact for this trial

Sophie Matheron, Pr, MD

01 40 25 72 39 sophie.matheron@aphp.fr

View on ClinicalTrials.gov More HIV-2 Infection trials